FDA Inspection
S&B Pharma LLCS&B Pharma LLC – FDA Inspection, Mar 7, 2011
Record Details
This FDA Inspection record concerns S&B Pharma LLC, with an inspection on March 7, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- S&B Pharma LLC
- Inspection Date
- March 7, 2011
- Product Type
- Drugs
View Company Profile
ID · 6bf5f665-1250-4ad8-ade9-8350684edec0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 714789
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of S&B Pharma LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2019 | Not classified | Kansas City District Office | Generic Drug Evaluation |
| March 16, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 27, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for S&B Pharma LLC
- FDA Inspection 1172319 - 2022-06-17
- FDA Inspection 1121238 - 2020-02-06
- FDA Inspection 1078320 - 2019-02-05
- FDA Inspection 1047928 - 2018-03-16
- FDA Inspection 1031001 - 2017-10-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.